Latest news
Roche (SWX:ROP) Starts Breast Cancer Trial With Evexta Bio Using Two Drug Candidates - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 22:14:43 GMTEvexta Bio and Roche plan Phase Ib trial of rupitasertib with giredestrant - Clinical Trials ArenaClinical Trials Arena · Wed, 05 Aug 2026 10:22:34 GMTEvexta pairs ex-Merck drug with Roche’s giredestrant - European Biotechnology MagazineEuropean Biotechnology Magazine · Wed, 05 Aug 2026 08:30:00 GMTEvexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer - Via RitzauVia Ritzau · Tue, 04 Aug 2026 07:00:00 GMT